Abstract
This paper presents the results of a molecular pharmacologicalanalysis of prothrombotic effects of oral estrogen drugs,as well asthe actual problem resoving methods of bioinformatics and systems biology. At the same time, the transdermal administration of estrogensallows not only to maintain a stable blood concentration, but alsoalmost completely avoid liver metabolism. Transdermal estrogen ischaracterized by pronounced pharmacokinetic advantages that can reducethe dosage of estrogen without losing effectiveness; avoidingundesirable effects of excessive activation of blood coagulation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
